Changes of the intestinal microbiota, short chain fatty acids, and fecal pH in patients with colorectal cancer

Digestive Diseases and Sciences

Volumn 58, Issue 6, 2013, Pages 1717-1726

  Ohigashi, Seiji ^a   Sudo, Kazuki ^a   Kobayashi, Daiki ^a   Takahashi, Osamu ^b   Takahashi, Takuya ^c   Asahara, Takashi ^c   Nomoto, Koji ^c   Onodera, Hisashi ^a  

^a ST LUKE'S INTERNATIONAL HOSPITAL   (Japan)

^b St Luke's Life Science Institute   (Japan)

^c YAKULT CENTRAL INSTITUTE FOR MICROBIOLOGICAL RESEARCH   (Japan)

Author keywords

Adenoma; Colorectal cancer; Fecal pH; Microbiota; Short chain fatty acid

Indexed keywords

ANTIBIOTIC AGENT; SHORT CHAIN FATTY ACID;

AGED; ANTIBIOTIC THERAPY; ARTICLE; ATOPOBIUM CLUSTER; BACTERIAL COUNT; BACTEROIDES FRAGILIS; BIFIDOBACTERIUM; CANCER PATIENT; CLOSTRIDIUM; CLOSTRIDIUM COCCOIDES; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM LEPTUM; COLON RESECTION; COLORECTAL ADENOMA; COLORECTAL CANCER; ENTEROBACTERIACEAE; ENTEROCOCCUS; FECES ANALYSIS; FECES PH; FEMALE; HUMAN; INTESTINE FLORA; LACTOBACILLUS BREVIS; LACTOBACILLUS CASEI; LACTOBACILLUS FERMENTUM; LACTOBACILLUS FRUCTIBORANS; LACTOBACILLUS GASSERI; LACTOBACILLUS PLANTARUM; LACTOBACILLUS REUTERI; LACTOBACILLUS RUMINIS; LACTOBACILLUS SAKEI; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PH; PREVOTELLA; PRIORITY JOURNAL; PSEUDOMONAS; RECTUM RESECTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STAPHYLOCOCCUS;

ADENOMA; AGED; AGED, 80 AND OVER; BACTERIAL LOAD; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; CROSS-SECTIONAL STUDIES; FATTY ACIDS, VOLATILE; FECES; FEMALE; HUMANS; HYDROGEN-ION CONCENTRATION; MALE; MICROBIAL CONSORTIA; MIDDLE AGED; MOLECULAR TYPING; NEOPLASM STAGING; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, BACTERIAL;

EID: 84879506452     PISSN: 01632116     EISSN: 15732568     Source Type: Journal    
DOI: 10.1007/s10620-012-2526-4     Document Type: Article

References (38)

1. Gill SR, Pop M, Deboy RT, et al. Metagenomic analysis of the human distal gut microbiome. Science. 2006;312:1355-1359.
2. Hooper LV, Macpherson AJ. Immune adaptations that maintain homeostasis with the intestinal microbiota. Nat Rev Immunol. 2010;10:159-169.
3. Hooper LV, Gordon JI. Commensal host-bacterial relationships in the gut. Science. 2001;292:1115-1118.
4. Neish AS. Microbes in gastrointestinal health and disease. Gastroenterology. 2009;136:65-80.
5. Bjorksten B, Sepp E, Julge K, et al. Allergy development and the intestinal microflora during the first year of life. J Allergy Clin Immunol. 2001;108:516-520.
6. Turnbaugh PJ, Ley RE, Mahowald MA, et al. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature. 2006;444:1027-1031.
7. Rawls JF. Enteric infection and inflammation alter gut microbial ecology. Cell Host Microbe. 2007;22:73-74.
8. Matsuki T, Watanabe K, Fujimoto J, et al. Use of 16S rRNA gene-targeted group-specific primers for real-time PCR analysis of predominant bacteria in human feces. Appl Environ Microbiol. 2004;70:7220-7228.
9. Eckburg PB, Bik EM, Bernstein CN, et al. Diversity of the human intestinal microbial flora. Science. 2005;308:1635-1638.
10. Zoetendal EG, Rajilic-Stojanovic M, de Vos WM. High-throughput diversity and functionality analysis of the gastrointestinal tract microbiota. Gut. 2008;57:1605-1615.
11. Ohara T, Yoshino K, Kitajima M. Possibility of preventing colorectal carcinogenesis with probiotics. Hepatogastroenterology. 2010;57:1411-1415.
12. Sobhani I, Tap J, Roudot-Thoraval F, et al. Microbial dysbiosis in colorectal cancer (CRC) patients. PLoS ONE. 2011;6:e16393.
13. Scanlan PD, Shanahan F, Clune Y, et al. Culture-independent analysis of the gut microbiota in colorectal cancer and polyposis. Environ Microbiol. 2008;10:789-798.
14. Matsuda K, Tsuji H, Asahara T, et al. Sensitive quantitative detection of commensal bacteria by rRNA-targeted reverse transcription-PCR. Appl Environental Microbiol. 2007;73:32-39.
15. Matsuda K, Tsuji H, Asahara T, et al. Establishment of an analytical system for the human fecal microbiota, based on reverse transcription- quantitative PCR targeting of multicopy rRNA molecules. Appl Environental Microbiol. 2009;75:1961-1969.
16. Bird AR, Brown IL, Topping DL. Starches, resistant starches, the gut microflora and human health. Curr Issues Intest Microbiol. 2000;1:25-37.
17. Wong JM, de Souza R, Kendall CW, et al. Colonic health: fermentation and short chain fatty acids. J Clin Gastroenterol. 2006;40:235-243.
18. Tjalsma H, Scholler-Guinard M, Lasonder E, et al. Profiling the humoral immune response in colon cancer patients: diagnostic antigens from Streptococcus bovis. Int J Cancer. 2006;119:2127-2135.
19. Ellmerich S, Djouder N, Scholler M, Klein JP. Production of cytokines by monocytes, epithelial and endothelial cells activated by Streptococcus bovis. Cytokine. 2000;12:26-31.
20. Hill MJ, Drasar BS, Hawksworth G, et al. Bacteria and aetiology of cancer of large bowel. Lancet. 1971;1:95-100.
21. Moore WE, Moore LH. Intestinal floras of populations that have a high risk of colon cancer. Appl Environ Microbiol. 1995;61:3202-3207.
22. Scheppach W. Effects of short chain fatty acids on gut morphology and function. Gut. 1994;35:S35-S38.
23. Augenlicht LH, Mariadason JM, Wilson A, et al. Short chain fatty acids and colon cancer. J Nutr. 2002;132:3804S-3808S.
24. Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell. 1990;61:759-767.
25. Johnson IT, Lund EK. Review article: nutrition, obesity and colorectal cancer. Aliment Pharmacol Ther. 2007;26:161-181.
26. Matsubara N. Epigenetic regulation and colorectal cancer. Dis Colon Rectum. 2012;55:96-104.
27. Liu Z, Qin H, Yang Z, et al. Randomised clinical trial: the effects of perioperative probiotic treatment on barrier function and post-operative infectious complications in colorectal cancer surgery - a double-blind study. Aliment Pharmacol Ther. 2011;33:50-63.
28. Gianotti L, Morelli L, Galbiati F, et al. A randomized double-blind trial on perioperative administration of probiotics in colorectal cancer patients. World J Gastroenterol. 2010;16:167-175.
29. Worthley DL, Le Leu RK, Whitehall VL, et al. A human, double-blind, placebo-controlled, crossover trial of prebiotic, probiotic, and synbiotic supplementation: effects on luminal, inflammatory, epigenetic, and epithelial biomarkers of colorectal cancer. Am J Clin Nutr. 2009;90:578-586.
30. Quintero E. Chemical or immunological tests for the detection of fecal occult blood in colorectal cancer screening? Gastroenterol Hepatol. 2009;32:565-576.
31. Mueller S, Saunier K, Hanisch C, et al. Differences in fecal microbiota in different European study populations in relation to age, gender, and country: a cross-sectional study. Appl Environ Microbiol. 2006;72:1027-1033.
32. Zhao L, Xu W, Ibrahim SA, et al. Effects of age and region on fecal microflora in elderly subjects living in Bama, Guangxi. China. Curr Microbiol. 2011;62:64-70.
33. Cummings JH, Pomare EW, Branch WJ, et al. Short chain fatty acids in human large intestine, portal, hepatic and venous blood. Gut. 1987;28:1221-1227.
34. Kikuchi H, Yamada T. Correlation between water-holding capacity of different types of cellulose in vitro and gastrointestinal retention time in vivo of rats. J Sci Food Agric. 1992;60:139-146.
35. Matsuki T. Development of quantitative PCR detection method with 16S rRNA gene-targeted genus- and species-specific primers for the analysis of human intestinal microflora and its application. Nippon Saikingaku Zasshi. 2007;62:255-261.
36. Matsuki T, Watanabe K, Tanaka R, et al. Distribution of bifidobacterial species in human intestinal microflora examined with 16S rRNA-gene-targeted species-specific primers. Appl Environ Microbiol. 1999;65:4506-4512.
37. Matsuda K, Tsuji H, Asahara T, et al. Sensitive quantification of Clostridium difficile by reverse transcription - quantitative PCR (RT-qPCR) targeting rRNA molecules. Appl Environ Microbiol. 2012;78:5111-5118.
38. Kikuchi E, Miyamoto Y, Narushima S, et al. Design of species-specific primers to identify 13 species of Clostridium harbored in human intestinal tracts. Microbiol Immunol. 2002;46:353-358.